Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ilya Safro

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virusTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2026
Evaluating the Impact of Blood Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive DisordersTammy H Cummings, Joseph Magagnoli, Sasha Sikirzhytskaya, et al.
AIDS (London, England)|September 9, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among people with HIVTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 6, 2019
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia ActivationMarina Aksenova, Justin Sybrandt, Biyun Cui, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Medrxiv : the Preprint Server for Health Sciences|January 31, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among patients with human immunodeficiency virusTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|February 12, 2026
Evaluating the Impact of Blood Brain Barrier-Penetrant ACE Inhibitors on HIV-Associated Neurocognitive DisordersTammy H Cummings, Joseph Magagnoli, Sasha Sikirzhytskaya, et al.
AIDS (London, England)|September 9, 2024
Exposure to angiotensin-converting enzyme inhibitors that cross the blood-brain barrier and the risk of dementia among people with HIVTammy H Cummings, Joseph Magagnoli, Aliaksandra Sikirzhytskaya, et al.
Journal of Neuroimmune Pharmacology : the Official Journal of the Society on Neuroimmune Pharmacology|December 6, 2019
Inhibition of the Dead Box RNA Helicase 3 Prevents HIV-1 Tat and Cocaine-Induced Neurotoxicity by Targeting Microglia ActivationMarina Aksenova, Justin Sybrandt, Biyun Cui, et al.
Pageof 2